About Bios Partners
Bios Partners is a company based in Fort Worth (United States) founded in 2017. It operates as a Commission-Based. Bios Partners offers products and services including Venture Capital Investment.
- Headquarter Fort Worth, United States
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bios Partners
Bios Partners offers a comprehensive portfolio of products and services, including Venture Capital Investment.
Venture capital is provided for biotech innovation development.
People of Bios Partners
Unlock access to complete
Funding Insights of Bios Partners
Detailed funding history for Bios Partners
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bios Partners
Investment portfolio details for Bios Partners
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bios Partners
Detailed financials for Bios Partners
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bios Partners Comparisons
Peer comparison for Bios Partners
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bios Partners
Detailed competitors of Bios Partners
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bios Partners
Complete news archive for Bios Partners
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bios Partners
Bios Partners was founded in 2017.
Bios Partners is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.
Bios Partners is engaged in providing venture capital to advanced biotech companies located in overlooked and under-invested markets across the Central United States. The firm focuses on disrupting geographic favoritism in venture capital by investing in compelling scientific opportunities that are often undervalued. Support is extended to cultivate and bring innovative solutions to market, particularly in sectors like pharmaceuticals, medical devices, cell therapy, digital medicines, and AI-driven therapeutics. Their portfolio includes clinical-stage companies addressing high-impact cancers, neurodegenerative disorders, rare genetic diseases, and vision loss.
Bios Partners offers Venture Capital Investment.